aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the target of a large decrease in short interest in September. As of September 15th, there was short interest totalling 411,800 shares, a decrease of 5.9% from the August 31st total of 437,400 shares. Based on an average daily volume of 256,600 shares, the days-to-cover ratio […]
aTyr Pharma, Inc. (NASDAQ:LIFE – Free Report) – Equities researchers at HC Wainwright boosted their FY2025 earnings estimates for aTyr Pharma in a report released on Thursday, September 21st. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will earn ($0.93) per share for the year, up from their prior forecast of ($0.99). […]
Foundation for Sarcoidosis Research announces largest Global Sarcoidosis Virtual Summit – Find Your Community, Find Your Life streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.